Results 101 to 110 of about 810,489 (200)

One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern

, 2023
A carbapenem-resistant Enterobacterales outbreak at a veterinary teaching hospital in the United States increased urgency for improved communication among diagnostic laboratories, public health authorities, veterinarians, and pet owners.
Nancy Muturi, Ingrid Garrison, Bryna Stacey, M.M. Chengappa, Kate KuKanich, Amy Burklund, Rob McGaughey, Tamara Gull, Shuping Zhang, Sasha Thomason   +9 more
core   +1 more source

The incidences and outcomes of acquiring multidrug-resistant Enterobacterales and enterococci colonization among hospitalized hematologic malignancy patients

Antimicrobial Stewardship & Healthcare Epidemiology
This study demonstrated the incidences of hospital-acquired colonization by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and vancomycin-resistant enterococci (VRE) of 22%, 8%, and 8 ...
Tutchaphol Rattanon, Wasithep Limvorapitak, Thana Khawcharoenporn   +2 more
doaj   +1 more source

Detection of carbapenemase production in Enterobacterales by mCIM and eCIM: a tertiary care hospital study

Iranian Journal of Microbiology
Background and Objectives: Carbapenem-resistant Enterobacterales (CRE) pose a major healthcare challenge due to high resistance rates and limited treatment options.
Touseefa Shafi, Anjum Ara Mir, Shagufta Roohi, Bashir Fomda, Sanam Rasool Wani, Tufail Ahmed, Samiah Yousuf   +6 more
doaj   +1 more source

From structured surveys to outbreak investigations: advancing genomic surveillance of carbapenem-resistant Enterobacterales within the European Antimicrobial Resistance Genes Surveillance Network

Frontiers in Public Health
The European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) was established in 2017 to support the European survey of carbapenem- and/or colistin-resistant Enterobacterales in 37 countries.
Anke Kohlenberg, Marius Linkevicius, Erik Alm, Emmanuel Robesyn, Olov Svartström, Daniel Palm, Dominique L. Monnet, Diamantis Plachouras, Barbara Albiger   +8 more
doaj   +1 more source

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

BACKGROUND: Use of anti-carbapenem-resistant Enterobacterales (anti-CRE) agents such as ceftazidime/avibactam has been associated with improved clinical outcome in cohorts that primarily include patients infected with CRE that are resistant to meropenem (
Ge, Lizhao, Weston, Gregory, Baum, Keri R, Kim, Angela C, Giri, Abhigya, Herc, Erica, Van Duin, David, Komarow, Lauren, Doi, Yohei, Kaye, Keith S, Zervos, Marcus, Gallagher, Jason C, Patel, Robin, Abbenante, Erin, Jacob, Jesse T, Huskins, W Charles   +15 more
core   +3 more sources

In vitro activity of ceftolozane/tazobactam against ESBL-producing enterobacterales in China: SMART 2016–2019

Journal of Global Antimicrobial Resistance
Objectives: To evaluate the in vitro susceptibility of ESBL-producing Enterobacterales isolates to ceftolozane/tazobactam (C/T), a combination of tazobactam (a ß-lactamase inhibitor) and a new antipseudomonal cephalosporin.
Wei Yu, Hui Zhang, Yingchun Xu, Ying Zhu, Peiyao Jia, Yue Kang, Qiwen Yang   +6 more
doaj   +1 more source

Carbapenemase-producing Carbapenem-Resistant Enterobacterales (CP-CRE), November 2024

This is a informational document is about Carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) by the Health and Human ...

core  

Antibiotic Susceptibility Profile of Carbapenem Resistant Escherichia Coli and Klebsiella Pneumoniae in Urinary Isolates from a Tertiary Care Hospital: An Observational Study

Journal of Nepal Medical Association
Introduction: Urinary tract infections are common in both hospital and community settings and impose a significant financial burden. Among Enterobacterales, Escherichia coli and Klebsiella pneumoniae are the leading uropathogens.
Gaurav Verma, Shradha Smriti, Rajesh Kumar Dash, Liza Das, Dipti Pattnaik, Nipa Singh, Subhra Snigdha Panda, Sukanta Tripathy   +7 more
doaj   +1 more source

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022

Journal of Global Antimicrobial Resistance
Objectives: To report trends in carbapenem resistance and difficult-to-treat resistance (DTR) among clinical isolates of Gram-negative priority pathogens collected by the ATLAS global surveillance program from 2018 to 2022.
Mark G. Wise, James A. Karlowsky, Naglaa Mohamed, Elizabeth D. Hermsen, Shweta Kamat, Andy Townsend, Adrian Brink, Alex Soriano, David L. Paterson, Luke S.P. Moore, Daniel F. Sahm   +10 more
doaj   +1 more source

Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia

Microbiology Spectrum
Carbapenem resistance in non-carbapenemase producing Enterobacterales can display susceptibility discordance (e.g., ertapenem-non-susceptible, meropenem-susceptible), often in patients with prior antimicrobial use. We aim to characterize risk factors for
Alex V. Stabler, William C. Shropshire, Allyson Young, Chun Feng, Hyunsoo Hwang, Samuel A. Shelburne, Nancy N. Vuong, Jovan Borjan   +7 more
doaj   +1 more source